Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
PATIENTS with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may face an increased risk of developing certain autoimmune diseases compared with those on dipeptidyl peptidase-4 inhibitors (DPP-4is), according to new real-world evidence from a large U.S
In late 2025, the White House announced a deal with two drug companies to lower the cost of their GLP-1 drugs
Why Leg Cramps May Occur During Wegovy Treatment Understanding the potential mechanisms behind leg cramps during Wegovy treatment requires consideration of both the medication's effects and the physiological changes associated with weight loss
Peels can be adapted to the needs of all skin types and are suitable for sensitivity to normal skin types
Apigenin-7-O--D-(-6"-p-coumaroyl)-glucopyranoside Treatment Elicits a Neuroprotective Effect through GSK-3 Phosphorylation-Mediated Nrf2 Activation
High-dose antioxidant supplements (vitamins C and E in megadoses) lack evidence for benefit in diabetes management and may interfere with certain laboratory tests or medications
US$ 20.37
US$ 23.43
US$ 25.15
US$ 24.13
US$ 29.33
US$ 20.22
US$ 21.81
US$ 21.55
US$ 23.33
